QUOTED. Aug. 17, 2018. Ben Hwang.
Start-up firm Profusa recently completed a successful funding round to help commercialize its novel biosensor for peripheral artery disease. The simplicity of the technology, once implanted, is one important feature, CEO Ben Hwang explains here.
Click here for a free trial of Medtech Insight